Boxer Capital, LLC
Crossover fundSan Diego · Seed–Late Stage
Investment thesis
Boxer Capital pursues innovation-focused investing in biotechnology companies aiming to transform medicine, particularly in precision and specialized medicine. Through disciplined, research-based analysis, the firm identifies opportunities across the entire drug life cycle, adapting to changes in the biotech ecosystem. Its team combines scientific expertise—including scientists who have led drug research and discovery—with nearly two decades of investment experience to produce a repeatable, bottom-up idea generation process with top-down oversight from its founder. Investments are evaluated through scientific, clinical, commercial, and regulatory lenses, seeking differentiated approaches, clear rationale, and strong management teams, with an emphasis on early-stage opportunities centered on novel, innovative drug targets.
Source: firm website, verified Sep 1, 2026.
Investments · 1 tracked
founders shown can be your intro pathPrecision oncology company known for its work on the KRAS oncogene; referenced as a long-term Boxer partnership.
Frequently asked questions
- What stage does Boxer Capital, LLC invest at?
- Boxer Capital, LLC invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Boxer Capital, LLC focus on?
- Boxer Capital, LLC focuses on Biotech, Healthtech, Longevity, Medical Devices.
- Where is Boxer Capital, LLC located?
- Boxer Capital, LLC is headquartered in San Diego, US.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Catalio is a New York-based investment firm focused on innovative healthcare, investing across the full lifecycle through private, public, and credit markets.